Antifungal susceptibility profile of Aspergillus species from patients with increased risk for aspergillosis
Journal
Macedonian Pharmaceutical Bulletin | Македонски Фармацевтски билтен
Date Issued
2022-02-25
Author(s)
Marija Stojanova
Zorica Zafirovik
Stojka Fustik
Abstract
Aspergillosis is the most common fungal infection caused by molds, especially in highrisk patients. The treatment of these diseases is based on the use of polyene and azole antifungal
drugs. Resistance rates of Aspergillus species to antifungal drugs vary widely across medical
centers around the world. Antifungal susceptibility testing of Aspergillus species to antifungal
agents could provide useful information for clinicians to make decision regarding the patient
therapy. The aim of the study was to evaluate the antifungal susceptibility profile of Aspergillus
species towards amphotericin B, itraconazole, voriconazole and caspofungin, isolated from
patients with increased risk for aspergillosis. During a 2-year period, clinical specimens from
125 patients divided into 4 groups according to clinical diagnosis and EORTC/MSG criteria,
were analysed at the Institute of Microbiology and parasitology, Faculty of Medicine, Skopje,
Republic of North Macedonia. These groups included patients with primary immune deficiency,
critically ill patients treated in intensive care units, patients with chronic aspergillosis and cystic
drugs. Resistance rates of Aspergillus species to antifungal drugs vary widely across medical
centers around the world. Antifungal susceptibility testing of Aspergillus species to antifungal
agents could provide useful information for clinicians to make decision regarding the patient
therapy. The aim of the study was to evaluate the antifungal susceptibility profile of Aspergillus
species towards amphotericin B, itraconazole, voriconazole and caspofungin, isolated from
patients with increased risk for aspergillosis. During a 2-year period, clinical specimens from
125 patients divided into 4 groups according to clinical diagnosis and EORTC/MSG criteria,
were analysed at the Institute of Microbiology and parasitology, Faculty of Medicine, Skopje,
Republic of North Macedonia. These groups included patients with primary immune deficiency,
critically ill patients treated in intensive care units, patients with chronic aspergillosis and cystic
File(s)![Thumbnail Image]()
Loading...
Name
Antifungal supsceptibility profile of Aspergillus species 67_2_005.pdf
Size
950.98 KB
Format
Adobe PDF
Checksum
(MD5):4d11cc21a89a868c8c24387e6b5c9a03